packageLaropiprantNicotinicAcid

laropiprant;nicotinic acid

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

This combination of laropiprant with nicotinic acid was developed to treat dyslipidemia by raising HDL cholesterol and lowering LDL cholesterol and triglycerides.

Unverified — written by glm-5.3-flash from general knowledge (no Wikidata entry found); not checked by a person.

name:laropiprant;nicotinic acid
ATC codes:—
DrugBank:DB00627

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown